Filing Details
- Accession Number:
- 0001209191-19-015224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 19:41:12
- Reporting Period:
- 2019-02-27
- Accepted Time:
- 2019-03-01 19:41:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1567514 | Intra-Cellular Therapies Inc. | ITCI | Pharmaceutical Preparations (2834) | 364742850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585697 | J. Lawrence Hineline | C/O Intra-Cellular Therapies, Inc. 430 East 29Th Street New York NY 10016 | Svp Of Finance Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-27 | 10,000 | $2.74 | 25,832 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-27 | 400 | $2.74 | 26,232 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-27 | 1,000 | $15.00 | 25,232 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-02-27 | 10,000 | $0.00 | 10,000 | $2.74 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-02-27 | 400 | $0.00 | 400 | $2.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2020-12-21 | No | 4 | M | Direct | |
| 9,600 | 2020-06-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 31, 2018.
- All shares underlying this option have vested.
Billionaire Hedge Funds
